| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/02/2008 | EP1871804A2 Reagents that bind ccx-ckr2 |
| 01/02/2008 | EP1871796A1 Vesiculins |
| 01/02/2008 | EP1871783A2 A method for the discovery of high-affinity, high specificity oligonucleotide and derivatized oligonucleotide sequences for target recognition |
| 01/02/2008 | EP1871426A2 Small activating rna molecules and methods of use |
| 01/02/2008 | EP1871425A2 Defective sindbis viral vectors |
| 01/02/2008 | EP1871418A2 Humanized anti-cd70 binding agents and uses thereof |
| 01/02/2008 | EP1871417A2 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 01/02/2008 | EP1871351A2 Compositions and their uses directed to aceytl-coa carboxylases |
| 01/02/2008 | EP1709058A4 Ntrk1 genetic markers associated with progression of alzheimer's disease |
| 01/02/2008 | EP1660646A4 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 01/02/2008 | EP1546171A4 Gene families associated with stomach cancer |
| 01/02/2008 | EP1485399A4 METHODS FOR ANALYZING METHYLATED CpG ISLANDS AND GC RICH REGIONS |
| 01/02/2008 | EP1252307B1 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 01/02/2008 | EP0830139B1 Modified myelin protein molecules |
| 01/02/2008 | EP0819133B1 Covalently linked oligonucleotide minor groove binder conjugates |
| 01/02/2008 | EP0728218B1 Hybridization probes for nucleic acid detection, universal stems, methods and kits |
| 01/02/2008 | CN101098882A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 01/02/2008 | CN100359016C Nucleotide specific for Escherichia coli 0108-type O-antigen |
| 01/02/2008 | CN100359011C Nucleic acid extraction device |
| 01/01/2008 | US7314975 Rubisco Activase with increased thermostability and methods of use thereof |
| 01/01/2008 | US7314928 Process for manufacturing morpholino-nucleotides, and use thereof for the analysis of and labelling of nucleic acid sequences |
| 01/01/2008 | US7314927 Anticode oligomer for prevention and treatment of cell proliferative disorders; antitumor, antisense, antiproliferative agents |
| 01/01/2008 | US7314926 Inhibiting cell proliferation, breast cancer, prostate cancer, cervical cancer, lung cancer, or tumor cells |
| 01/01/2008 | US7314925 Vectors comprise avian lysozyme leader peptide for targetting the endoplasmic reticulum; heparin affinity chromatography |
| 01/01/2008 | US7314924 Polynucleotide encoding a genetically engineered P30 antigen |
| 01/01/2008 | US7314923 The present invention relates to novel oligonucleotide analogues, which exhibit antisense or antigene activity having excellent stability, or exhibit excellent activity as a detection agent (probe) for a specific gene or as a primer |
| 01/01/2008 | US7314922 Cutaneous T-cell lymphoma associated genes; expression in malignant tumors and in ordinary testis tissue, diagnosis and therapy of tumoral diseases |
| 01/01/2008 | US7314920 Antibodies against the PRO4340 polypeptide |
| 01/01/2008 | US7314919 Human recombinant antibody against the hepatitis C (HCV) non structural NS3 protein nucleic acid and uses thereof |
| 01/01/2008 | US7314918 PRO6246 antibodies |
| 01/01/2008 | US7314913 PRO1891 polypeptides |
| 01/01/2008 | US7314868 fusing cells; nucleic acid vector comprises a nucleotide sequence encoding a measles virus F glycoprotein and a nucleotide sequence encoding a chimeric measles virus H glycoprotein; nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
| 01/01/2008 | US7314864 Isolated polypeptid of 24-amino acids; the clone suppressed neuronal death induced by all of the known types of early-onset familial Altzheimers Disease genes |
| 01/01/2008 | US7314757 Drought inducible promoters and uses thereof |
| 01/01/2008 | US7314756 Plant tubby-like proteins |
| 01/01/2008 | US7314754 Polynucleotide encoding the hOT7T175 G protein coupled receptor |
| 01/01/2008 | US7314753 Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli |
| 01/01/2008 | US7314750 Addressable oligonucleotide array of the rat genome |
| 01/01/2008 | US7314747 SMRT co-repressors, transcriptional co-repressors that interact with nuclear hormone receptors |
| 01/01/2008 | US7314746 Apparatus and method for preparative scale purification of nucleic acids |
| 01/01/2008 | US7314743 Xylanases having increased stability in harsh industrial environments, such as increased pH and/or temperature |
| 01/01/2008 | US7314742 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/01/2008 | US7314739 Lipase variants |
| 01/01/2008 | US7314738 Nucleotide sequences coding hydantoinase/hydrolases for producing pharmaceuticals, chemical industrial products and food; for producing the D-amino acid efficiently from the 5-substituted hydantoin |
| 01/01/2008 | US7314734 Muteins of placental growth factor type 1, preparation method and application thereof |
| 01/01/2008 | US7314730 Identifying modulator which inhibit membrane bound protease activity for use in treatment and prevention of atherosclerosis, infections, inflammation, cell proliferative, neurodegenerative and respiratory system disorders |
| 01/01/2008 | US7314714 Method of oligonucleotide synthesis |
| 01/01/2008 | US7314713 Screening of the TBC1D1 gene for germline mutations; presence of cytidine to thymidine alteration identifies the subject as being at risk for developing obesity. |
| 01/01/2008 | US7314712 in such a way that no heterologous sequence is retained after the mutagenesis is complete; employ integrative recombinant oligonucleotides (IROs); kits; genetic engineering |
| 01/01/2008 | US7314711 Assays employing electrochemiluminescent labels and electrochemiluminescence quenchers |
| 01/01/2008 | US7314710 Method for replicating the hepatitis C virus |
| 01/01/2008 | US7314708 Electronically controlling the transport and attachment of specific binding entities to specific micro-locations in the synthesis of biopolymers such as DNA and polypeptides; producing a complement of a self-addressable electronic device addressed with specific DNA sequences |
| 01/01/2008 | US7314637 Method of administering liposomal encapsulated taxane |
| 01/01/2008 | US7314627 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 01/01/2008 | US7314626 Peptide antibiotic conjugate for use in recognition and elimination of infections agents or neoplasms; antitumor agents; bactericides |
| 01/01/2008 | US7314622 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 01/01/2008 | US7314613 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells |
| 12/30/2007 | CA2558160A1 Antisense oligonucleotides for treatment of muscle wasting |
| 12/27/2007 | WO2007149870A2 Two-color fluorescent reporter for alternative pre-mrna splicing |
| 12/27/2007 | WO2007149521A2 Nucleotide motifs providing localization elements and methods of use |
| 12/27/2007 | WO2007148091A2 Dna molecules and methods |
| 12/27/2007 | WO2007147265A1 Polynucleotides and polypeptide sequences involved in cancer |
| 12/27/2007 | WO2007102892A3 Device for monitoring polymerase chain reactions |
| 12/27/2007 | WO2007087462A3 Methods and compositions for cancer therapy using a novel adenovirus |
| 12/27/2007 | WO2007040568A3 Production and use of human butyrylcholinesterase |
| 12/27/2007 | WO2006076470A3 High-content screening for drugs against cancer and age-related diseases |
| 12/27/2007 | WO2005099390A3 Compositions and methods for reverse transcription |
| 12/27/2007 | WO2005069859A3 Compositions and methods for modulating dhr96 |
| 12/27/2007 | WO2005019267A8 Tie1-binding ligands |
| 12/27/2007 | US20070300331 Plant artificial chromosome platforms via telomere truncation |
| 12/27/2007 | US20070300328 introducing into a plant cell a chimeric gene comprising an isolated promoter region that controls epidermis-specific expression operably linked to the desired coding sequence, said promoter region comprising a first sequence originating from the promoter of a GSTA1 and 2nd from intron of a WIR1 genes |
| 12/27/2007 | US20070300326 Grg33, grg35, grg36, grg37, grg38, grg39 and grg50: novel epsp synthase genes conferring herbicide resistance |
| 12/27/2007 | US20070300325 Grg32: a novel epsp synthase gene conferring herbicide resistance |
| 12/27/2007 | US20070300321 Herbicide-Resistant Sunflower Plants, Polynucleotides Encoding Herbicide-Resistant Acetohydroxyacid Synthase Large Subunit Proteins, and Methods of Use |
| 12/27/2007 | US20070300319 rice with a reduced starch branching enzyme IIa (SBEIIa) activity in the endosperm; food and non-food products; transgenic plants |
| 12/27/2007 | US20070300314 Tomato plants having higher levels of resistance to botrytis |
| 12/27/2007 | US20070299255 Compositions and Methods for Amplification and Cloning of Near Full-Length Viral Genome Samples |
| 12/27/2007 | US20070299254 nucleic acid amplification which is robust and efficient, while reducing the appearance of side products; increased sensitivity, convenience, accuracy and reliability |
| 12/27/2007 | US20070299253 siRNA targeting vacuolar ATPase |
| 12/27/2007 | US20070299244 Liposome allowing liposome-entrapped substance to escape from endosome |
| 12/27/2007 | US20070299028 Backbone modifications to modulate oligonucleotide targeting in vivo |
| 12/27/2007 | US20070299026 Immunosuppressive Cytokine |
| 12/27/2007 | US20070299025 Method for Detecting the Risk of Cardiovascular Diseases Such as Acute Myocardial Infarction and Coronary Heart Disease By Analysing Defesin |
| 12/27/2007 | US20070299022 Antisense Oligonucleotide to Inhibit Melanoma Inhibitory Activity Mia |
| 12/27/2007 | US20070299021 Modified Tailed Oligonucleotides |
| 12/27/2007 | US20070298973 Methods and compositions comprising Renilla GFP |
| 12/27/2007 | US20070298506 Gene methylation in cancer diagnosis |
| 12/27/2007 | US20070298498 Adenoviral Amplicon and Producer Cells for the Production of Replication-Defective Adenoviral Vectors, Methods of Preparation and Use Thereof |
| 12/27/2007 | US20070298492 Novel PTH responsive gene |
| 12/27/2007 | US20070298491 Human Secreted Proteins |
| 12/27/2007 | US20070298490 or a protein or polypeptide substantially similar thereto, derived from the thermophilic fungus Talaromyces thermophilus; use as a surface coating of materials to provide beneficial properties |
| 12/27/2007 | US20070298489 Expression vector comprising nucleotide sequences coding epidermal growth factor for use in identifying modulators for treatment and prevention of autoimmune, diabetic, bone, infectious and arthritic disorders |
| 12/27/2007 | US20070298481 Method for Producing a Useful Intermediate in Alkaloid Biosynthesis By Using Rnai Technology |
| 12/27/2007 | US20070298473 Pet family of efflux proteins |
| 12/27/2007 | US20070298470 Improving manufacture of clavulanic acid; DNA encoding genes essential for clavam-2-carboxylate (C2C), 2-hydroxymethylclavam (2HMC), or 2-(3-alanyl)clavam (AC) biosynthesis in S. clavuligerus which are not essential for clavulanic acid biosynthesis |
| 12/27/2007 | US20070298469 N-epsilon-acyl-l-lysine-specific aminoacylase |
| 12/27/2007 | US20070298463 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
| 12/27/2007 | US20070298461 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use |
| 12/27/2007 | US20070298459 Death Domain Containing Receptor 6; severe combined immunodeficiency (SCID); adenosine deaminase deficiency, agammaglobulinemia Bruton's disease |
| 12/27/2007 | US20070298455 Method For Preparing A Modified Host Cell |